ESR1 and breast carcinoma: These compounds showed a moderate solubility (180 μM) in Dulbecco’s modified eagle medium (DMEM) [45], and exhibited much stronger antiproliferative effects than quercetin in estrogen receptor-positive human breast cancer cell line (MCF-7), likely due to their better accumulation capability [44].